Saad Usmani
Division Chief, Plasma Cell Disorders; Director, Clinical Research Hem Malignancies (Levine Cancer Institute). Views are my own,RT not endorsement
Last synced from Twitter 82d ago
ACP: Falsely Accusing Physicians of Overcounting COVID-19 Deaths For Financial Gain is Reprehensible | ACP Newsroom | ACP
Statement attributable to: Jacqueline W. Fincher, MD, MACP President, American College of Physicians Philadelphia, PA (October 25, 2020) – The American College of Physicians (ACP), on behalf of internal medicine physicians (internists) and related...
Saad Usmani
ACP: Falsely Accusing Physicians of Overcounting COVID-19 Deaths For Financial Gain is Reprehensible | ACP Newsroom | ACP
85d
COVID’s Impact on Cancer Prevention and Care | SWOG
Earlier this month, ASCO published results of its sweeping annual National Cancer Opinion Survey, an online questionnaire answered by 4,012 American adults – including 1,142 who are undergoing cancer treatment or who are cancer survivors.
Findings...
Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults | NEJM
Original Article from The New England Journal of Medicine — Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
Inherited causes of clonal haematopoiesis in 97,691 whole genomes
Analysis of 97,691 high-coverage human blood DNA-derived whole-genome sequences enabled simultaneous identification of germline and somatic mutations that predispose individuals to clonal expansion of haematopoietic stem cells, indicating that both...
Time to End "Manels" in Clinical Trial Leadership - PubMed
Time to End "Manels" in Clinical Trial Leadership
1
Saad Usmani
A few of us advocate for this, kudos to the authors @jmikhaelmd @ninashah33 #MedTwitter #MedStudentTwitter
96d
New developments in maintenance therapy for multiple myeloma
Graham Jackson, MBBS, FRCP, FRCPath, MD, Newcastle upon Tyne Hospitals NHS Trust, Newcastle, UK, discusses maintenance therapy when treating multiple...
Atrium Health and Wake Forest Baptist Health Combine, Create Next-Generation Academic Health System
A new era of health care was ushered in today as Atrium Health and Wake Forest Baptist Health, including Wake Forest School of Medicine, officially joined together as a single enterprise, Atrium Health.
Registration
Registration Register Now
Welcome to the 5th Translational Research E-Conference on Multiple Myeloma!
#ESHMM2020
Live Conference: October 8-11, 2020
On demand Conference: September 29-October 21, 2020
Dear Colleagues and...
Atrium Health and Wake Forest Baptist Health Combine, Create Next-Generation Academic Health System
A new era of healthcare was ushered in today as Atrium Health and Wake Forest Baptist Health, including Wake Forest School of Medicine, officially joined together as a single enterprise, Atrium Health.
Saad Usmani
Atrium Health and Wake Forest Baptist Health Combine, Create Next-Generation Academic Health System #AtriumProud @AtriumHealth @LevineCancer @ZainabShd @clttumordoc @Singh011Jaspal @clttumordoc
102d
Business Group on Health Honors Atrium Health with Best Employers: Excellence in Health & Well-Being Platinum Award
Business Group on Health, a non-profit association of more than 440 large employers, honored Atrium Health for providing one of the best workforce health and employee well-being programs in the nation.
Dying in a Leadership Vacuum | NEJM
Editorial from The New England Journal of Medicine — Dying in a Leadership Vacuum
Saad Usmani
Dying in a Leadership Vacuum | NEJM —— mic drop moment #COVID19 #MedStudentTwitter #medtwitter
103d
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
A new bispecific CAR T cell product targeting the CD20 and CD19 antigens demonstrates an excellent safety profile and high clinical efficacy in patients with B cell non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Some Insurers End Pandemic Waivers of Fees and Deductibles for Telehealth
The coronavirus outbreaks had prompted the nation’s largest insurers to stop charging co-pays or requiring deductibles for virtual visits, but some consumers will now have to pay those fees again.
Why do we not see curative CAR T-cell therapy in MM (compared to DLBCL and ALL)?
During the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the Multiple Myeloma Hub spoke to Noopur Raje, Massachusetts General Hospital, Boston, US, about chimeric antigen receptor T-cell therapy for...
The evolving role of IMiDs
Xavier Leleu, MD, PhD, Poitiers University Hospital, Poitiers, France, discusses the importance of immunomodulatory imide drugs (IMiDs) in multiple myeloma...
Helping Laura and Katherine get through my death., organized by Jeffrey McKnight
I am dying of lymphoma. My wife, Laura, has been nothing but a hero… Jeffrey McKnight needs your support for Helping Laura and Katherine get through my death.